FBFilip Björklund

Filip Björklund

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Filip Björklund has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Magnus Ekström

    Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology and Palliative Medicine, Lund, Sweden

    5 shared publications
  • Andreas Palm

    Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University

    4 shared publications
  • Josefin Sundh

    Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro University

    4 shared publications
  • Magnus Ekström

    Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine, Allergology, and Palliative Medicine, Lund University, Lund, Sweden

    2 shared publications
  • Andreas Palm

    Uppsala University, Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala, Sweden; and Region of Gävleborg, Gävle Hospital, Centre for Research and Development, Gävle, Sweden

    1 shared publication
  • Jenny Theorell Haglöw

    Uppsala University, Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala, Sweden

    1 shared publication

Latest Publications

  • Open Access

    Fall-related injuries in long-term oxygen therapy: Incidence and predictive factors

    by Filip Björklund, Andreas Palm, Josefin Sundh, Magnus Ekström

    Introduction: Fall-related injuries are a common cause of morbidity and impaired quality of life among patients with severe respiratory disease. Use of long-term oxygen therapy (LTOT) may be associated with a further increased risk. Methods: This was a longitudinal study of patients starting LTOT between 2006 and 2023 in the Swedish DISCOVERY cohort. Rates of healthcare contact due to three types of fall-related injuries (distal radius fracture, hip fracture, and skull trauma) were compared to those of age- and sex-matched population controls using nationwide registries. For patients on LTOT, pre-identified potentially predictive factors were analyzed against a composite outcome of any fall-related injury using Cox and Fine-Gray regression, independently, adjusting for age, sex and Charlson Comorbidity Index (CCI), and in a joint model adjusting for all predictive factors. Results: A total 16,915 patients with LTOT (mean age 76±9 years, 57% female, 63% underlying COPD) and an equal number of matched controls were included. Compared with controls, LTOT patients had increased overall rates of both hospitalizations (15.5 vs 7.3 per 100 patient-years) and outpatient (16.9 vs 13.6 per 100 patient-years) healthcare contacts due to fall-related injuries, driven by hip fractures and skull trauma, whereas distal radius fractures were more common among patients without LTOT. The strongest independent predictive factors for fall-related injury during LTOT were history of previous fall-related injury (HR1.8; 95% confidence interval 1.7-2.0) and increased CCI. The overall predictive capability of the model was poor (C-statistic 0.65). Conclusion: Patients on LTOT have a high rate of health care contacts due to hip fractures and skull trauma, but whether this increase is caused by use of oxygen equipment or underlying frailty remains unknown. While individual falls were difficult to predict, indicators such as previous fall injury and comorbidities, may inform optimized follow-up and interventions aimed at mitigating risk.

  • Open Access

    Similar risk of hospitalization and mortality for patients continuing and discontinuing LTOT

    by Filip Björklund, Andreas Palm, Josefin Sundh, Yet H. Khor, Magnus Ekström

    Introduction: While the characteristics and medical management of patients treated with long-term oxygen therapy (LTOT) have transformed during the last decades, the evidence base for LTOT itself remains largely unchanged. This study aimed to compare the risk of hospitalization and death among hypoxemic patients discontinuing LTOT, with that of controls continuing therapy. Methods: This was a retrospective observational study of patients with LTOT included in the DISCOVERY cohort, using elements of target trial emulation. Patients who fulfilled LTOT criteria but discontinued treatment with LTOT within 90 days of initiation, not due to improving oxygenation or change of treatment modality, were identified. The risk of hospitalization and death as a composite outcome, and the risks of individual outcomes of hospitalization and death, were compared with age-, sex- and disease type-matched controls who continued LTOT, using Cox regression adjusted for confounders. Results: In total, 79 patients discontinuing LTOT and 395 controls were analyzed, both groups with a mean age of 73 (SD ± 11) years, 72% females, 65% underlying COPD. In adjusted Cox regression models, discontinuing LTOT was not associated with an increased risk of hospitalization or death (hazard ratio (HR) 1.0 95% Confidence interval (CI) 0.78–1.3), hospitalization (HR 0.99 95% CI 0.75–1.3), or death (HR 0.79 95% CI 0.61-1.0). Conclusion: In this study, patients fulfilling LTOT initiation criteria who discontinued therapy were not found to be at an increased risk of hospitalization or death, suggesting equipoise for a randomized trial of LTOT discontinuation or non-initiation in selected patient groups.


  • Open Access

    Longer daily oxygen use associates with more adverse events, symptoms, and worse health status in long-term oxygen therapy

    by Filip Björklund, Magnus Ekström

    Introduction: Use of long-term oxygen therapy (LTOT) for more than 15 h per day does not reduce mortality or hospitalizations, but may increase the risk of adverse events. We evaluated the relationship between daily oxygen use duration and adverse events, symptoms, and health status in patients on LTOT. Methods: This was a cross-sectional survey study of a random sample ( N = 650) of adults with ongoing LTOT in Sweden. Oxygen use (h/day) was reported, and associations were analyzed with adverse events, symptom severities (revised Edmonton Symptom Assessment System), sleep duration and quality, and health status (COPD assessment test [CAT]). Results: In total, surveys from 204 patients were analyzed; 60% female, mean age 75.3 (SD 8.7) years. Swedevox baseline characteristics were similar between sampled respondents and non-respondents. Patients reporting 24 h of daily oxygen use (53.4%) also reported a higher number of total adverse events, higher ratings of dyspnea, depression and anxiety, and worse health status, compared to those reporting fewer hours of oxygen use. A longer daily duration of oxygen use also associated with a higher number of experienced adverse events, higher ratings of dyspnea and anxiety, and worse rated health status in crude and adjusted linear regression models. No associations were seen between oxygen use duration and sleep quality or duration. Conclusion: More adverse events, a higher severity of some symptoms, and worse health status are seen among patients with a longer daily duration of oxygen use. Further research is needed to establish evidence of causality.


  • Breathlessness and exercise performance to predict mortality in long-term oxygen therapy

    by Filip Björklund, Andreas Palm, Jwan Abdulrazak Gorani, Zainab Ahmadi, Josefin Sundh, Jenny Theorell Haglöw, Mirjam Ljunggren, Ludger Grote, Karin Wadell, Magnus Ekström

    Background: Patients with chronic respiratory failure treated with long-term oxygen therapy (LTOT) often have severe breathlessness, impaired exercise performance, and high but variable mortality that is difficult to predict. We aimed to evaluate breathlessness and exercise performance upon starting LTOT as predictors of overall and short-term mortality. Methods: This was a longitudinal, population-based study of patients who initiated LTOT between 2015-2018 in Sweden. Breathlessness was measured using the Dyspnea Exertion Scale, and exercise performance using the 30s-Sit-To-Stand test. Associations with overall and three-month mortality were analyzed using Cox-regression. Subgroup analyses were performed for patients with COPD and ILD respectively. The predictive capacity of models was assessed using a C-statistic. Results: A total of 441 patients (57.6% female, aged 75.4±8.3 years) were analyzed. Both breathlessness and exercise performance were independently associated with overall mortality in the crude models, but only exercise performance remained independently associated with overall mortality when models were adjusted for other predictors, when three-month mortality was analyzed, or when breathlessness and exercise capacity were analyzed concurrently. The multivariable model including exercise performance but not breathlessness provided a relatively high predictive capacity for overall mortality, C-statistic 0.756 (95% CI 0.702-0.810). Similar results were seen in the COPD and ILD subgroups. Conclusion: Exercise performance as measured by the 30s-STS may be useful to identify patients with higher mortality on LTOT for optimized management and follow-up.

  • Open Access

    Breathlessness and exercise performance to predict mortality in long-term oxygen therapy – The population-based DISCOVERY study

    by Filip Björklund, Andreas Palm, Jwan Abdulrazak Gorani, Zainab Ahmadi, Josefin Sundh, Jenny Theorell-Haglöw, Mirjam Ljunggren, Ludger Grote, Karin Wadell, Magnus Ekström


  • Open Access

    Adverse Effects, Smoking, Alcohol Consumption, and Quality of Life during Long-Term Oxygen Therapy: A Nationwide Study

    by Filip Björklund, Magnus Ekström

    Rationale: Long-term oxygen therapy (LTOT) is prescribed for at least 15 hours per day and often used by patients for several years, but knowledge is limited regarding adverse effects, risk exposures, and health-related quality of life (HrQoL) among those treated. Objectives: To determine the prevalence of adverse effects, smoking, and alcohol consumption and their relations to HrQoL among patients treated with LTOT. Methods: This was a cross-sectional survey of a randomized sample of adults with ongoing LTOT in the Swedish National Registry for Respiratory Failure (Swedevox). Patient characteristics and the prevalence of 26 prespecified adverse effects, smoking, and alcohol consumption, were compared between respondents with better and worse HrQoL on the chronic obstructive pulmonary disease assessment test. Results: A total of 151 respondents were included (mean age, 74.7 yr [standard deviation, 8.6 yr]; 58.9% women; median LTOT duration, 2.2 yr [interquartile range, 1.0–3.8 yr]). Characteristics upon starting LTOT were similar between respondents and nonrespondents. Active smoking was very rare (n = 4, 2.6%). For alcohol use, 67.2% of participants reported no consumption during an average week, whereas risk use was reported by 25.8% of men and 16.9% of women. The most prevalent adverse effects were reduced mobility or physical activity (70.9%), dry mouth (69.5%), congestion or nasal drip (61.6%), increased tiredness (57.0%), and dry nose (53.0%). Patients with higher numbers of total and systemic adverse effects experienced worse HrQoL, whereas no associations were found for smoking status or alcohol consumption. The majority (54.8%) of adverse effects were untreated and unreported to health professionals. Conclusions: Adverse effects are common among patients with LTOT and are associated with worse HrQoL. As the majority of adverse effects had not been discussed or treated, structured assessment and management of risk exposures and adverse effects is warranted.